Retreatment with erlotinib: Regain of TKI sensitivity following a drug holiday for patients with NSCLC who initially responded to EGFR-TKI treatment

Details 詳細情報について

• CRID

  1364233270238299904

• DOI

  10.1016/j.ejca.2011.06.046

• ISSN

  09598049

• Web Site

  https://api.elsevier.com/content/article/PII:S0959804911004746?httpAccept=text/xml

  https://api.elsevier.com/content/article/PII:S0959804911004746?httpAccept=text/plain

• Data Source

  • Crossref